22

Listed companies

19

Private companies

40

Insiders

Relation chart of related listed companies: Zydus Lifesciences Limited

Active Relations

Past Relations

Relationship chart for related private companies: Zydus Lifesciences Limited

Active Relations

Past Relations

Related private companies: Zydus Lifesciences Limited

Desai Brothers Ltd.

Food: Major Diversified

Zydus Animal Health Ltd.

Pharmaceuticals: Major

Cadmach Machinery Co. Pvt Ltd.

Industrial Machinery

The Dailforhealth (India) Ltd.

Drugstore Chains

Zydus Technologies Ltd.

Pharmaceuticals: Major

Western Ahmedabad Effluent Conveyance Co. Pvt Ltd.

Bayer Zydus Pharma Pvt Ltd.

Medical Distributors

Cadila Laboratories Pvt Ltd.

Chemicals: Major Diversified

Zydus Takeda Healthcare Pvt Ltd.

Pharmaceuticals: Major

Zydus Hospitals & Healthcare Research Pvt Ltd.

Hospital/Nursing Management

Indian Pharmaceutical Alliance

Miscellaneous Commercial Services

Zydus Healthcare Ltd.

Pharmaceuticals: Major

Zydus Wellness Products Ltd.

Pharmaceuticals: Other

Zydus Foundation

Investment Trusts/Mutual Funds

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major10
Medical Distributors2
Industrial Machinery2
Food: Major Diversified2
Hospital/Nursing Management2
Engineering & Construction2
Pharmaceuticals: Other2
Investment Trusts/Mutual Funds1
Wholesale Distributors1
Home Furnishings1

Countries of related companies

India41
Logo Zydus Lifesciences Limited
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.
Employees
27,917